Unum Group (NYSE:UNM) Issues Quarterly Earnings Results, Misses Expectations By $0.11 EPS

Unum Group (NYSE:UNM) posted its earnings results on Tuesday. The financial services provider reported $2.03 earnings per share for the quarter, missing the consensus estimate of $2.14 by ($0.11), Zacks reports. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. Unum Group updated its FY 2025 guidance to 9.120-9.450 EPS.

Unum Group Stock Performance

Shares of NYSE:UNM opened at $75.91 on Wednesday. The business’s fifty day moving average price is $74.22 and its two-hundred day moving average price is $64.99. Unum Group has a fifty-two week low of $46.64 and a fifty-two week high of $77.69. The stock has a market capitalization of $13.86 billion, a price-to-earnings ratio of 8.21, a price-to-earnings-growth ratio of 1.08 and a beta of 0.80. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.28 and a quick ratio of 0.28.

Unum Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be given a $0.42 dividend. This represents a $1.68 dividend on an annualized basis and a yield of 2.21%. The ex-dividend date is Friday, January 24th. Unum Group’s dividend payout ratio (DPR) is 18.18%.

Insider Buying and Selling at Unum Group

In other news, EVP Lisa G. Iglesias sold 5,000 shares of the stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $72.61, for a total transaction of $363,050.00. Following the sale, the executive vice president now owns 35,840 shares in the company, valued at approximately $2,602,342.40. This represents a 12.24 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Gloria C. Larson sold 10,000 shares of the stock in a transaction on Thursday, November 21st. The stock was sold at an average price of $74.50, for a total value of $745,000.00. Following the sale, the director now owns 121,491 shares in the company, valued at $9,051,079.50. The trade was a 7.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 99,664 shares of company stock worth $7,450,380 over the last three months. Company insiders own 0.93% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on UNM shares. Evercore ISI upgraded Unum Group from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $67.00 to $84.00 in a report on Thursday, November 14th. Wells Fargo & Company upped their target price on Unum Group from $74.00 to $81.00 and gave the company an “overweight” rating in a research note on Tuesday, January 14th. BMO Capital Markets began coverage on Unum Group in a research note on Thursday, January 23rd. They issued an “outperform” rating and a $91.00 target price for the company. Bank of America upped their target price on Unum Group from $54.00 to $63.00 and gave the company a “neutral” rating in a research note on Thursday, October 10th. Finally, Morgan Stanley upped their target price on Unum Group from $62.00 to $64.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 30th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $79.00.

Unum Group Company Profile

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.